The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMobeus I&g Regulatory News (MIX)

Share Price Information for Mobeus I&g (MIX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 56.00
Bid: 54.50
Ask: 57.50
Change: 0.00 (0.00%)
Spread: 3.00 (5.505%)
Open: 56.00
High: 57.50
Low: 56.00
Prev. Close: 56.00
MIX Live PriceLast checked at -
Mobeus Income & Growth VCT is an Investment Trust

To provide investors with a regular income stream, by way of tax-free dividends, generated from income and capital returns, while continuing at all times to qualify as a VCT.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of Suppl.Prospcts

25 Feb 2020 15:15

RNS Number : 0954E
Mobeus Income & Growth VCT PLC
25 February 2020
 

Joint Announcement

 

Mobeus Income & Growth VCT plc (MIG), Mobeus Income & Growth 2 VCT plc (MIG 2), Mobeus Income & Growth 4 VCT plc (MIG 4) and The Income & Growth VCT plc (I&G) (together the Companies)

 

Issue of Third Supplementary Prospectus

The Companies issued a prospectus (constituted by a summary, securities note and registration document) dated 25 October 2019 (Prospectus) relating to the offers for subscription to raise, in aggregate, up to £38 million, with over-allotment facilities to raise, in aggregate, up to a further £20 million and, in the case of Mobeus Income & Growth 2 VCT plc only, a further increase to raise up to a further £2.1 million (Offers and each an Offer). The Prospectus has been updated through the issue of supplementary prospectuses dated 20 December 2019 and 7 February 2020 (First Supplementary Prospectus and Second Supplementary Prospectus respectively).

The Companies have each announced utilisation of their over-allotment facilities. I&G has announced that its Offer was fully subscribed, that all I&G Offer Shares have been allotted and that its Offer has closed. MIG and MIG 4 have each announced that their respective Offers are fully subscribed.

On 14 February 2020, the Companies announced the realisation of investment holdings in three companies held commonly in their investment portfolios. In respect of MIG, MIG 2 and MIG 4, the impact of the realisations on the unaudited net assets and net asset value per share as at 30 June 2019 is a significant new factor (Realisation Impact) in relation to the Prospectus (as updated by the First Supplementary Prospectus and the Second Supplementary Prospectus).

The Boards of the Companies announce that they have published a third supplementary prospectus (Third Supplementary Prospectus) to the Prospectus (as updated by the First Supplementary Prospectus and the Second Supplementary Prospectus) as a result of the Realisation Impact.

 

A copy of the Third Supplementary Prospectus has been submitted to the Financial Conduct Authority and will shortly be available for inspection at the National Storage Mechanism, which is located at:

 

www.morningstar.co.uk/uk/nsm

 

Copies of this Third Supplementary Prospectus, together with the Prospectus, the First Supplementary Prospectus and the Second Supplementary Prospectus, are available from the following website:

 

www.mobeus.co.uk/vct-fundraising

 

For further information please contact:

Rob Brittain

Mobeus Equity Partners LLP, Company Secretary, on 020 7024 7600 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
PSPFLFLEFLIEFII
Date   Source Headline
24th Apr 20247:00 amRNSDividend Declaration
15th Apr 20247:00 amRNSAnnual Financial Report
2nd Apr 20249:30 amRNSTotal Voting Rights and Capital
1st Mar 202411:00 amRNSTotal Voting Rights and Capital
28th Feb 20243:30 pmRNSMerger Discussions
27th Feb 20242:00 pmRNSRealisation of Investment: Master Removers Group
22nd Feb 202411:00 amRNSNet Asset Value(s)
1st Feb 202411:46 amRNSVoting Rights and Capital
2nd Jan 20241:00 pmRNSVoting Rights and Capital
21st Dec 202312:00 pmRNSTransaction in Own Shares
1st Dec 20237:00 amRNSTotal Voting Rights
27th Nov 20237:00 amRNSTransaction in Own Shares
10th Nov 20231:30 pmRNSInterim Management Statement
1st Nov 20237:00 amRNSTotal Voting Rights
12th Oct 20237:00 amRNSStatement re Change of Registrar
2nd Oct 20237:00 amRNSTotal Voting Rights
27th Sep 20231:00 pmRNSTransaction in Own Shares
21st Sep 202310:15 amRNSDividend Declaration
18th Sep 20231:00 pmRNSHalf-year Report
1st Sep 20237:00 amRNSTotal Voting Rights
1st Aug 20237:00 amRNSTotal Voting Rights
26th Jul 20232:30 pmRNSInvestment Adviser Co-investment Incentive Scheme
3rd Jul 20237:00 amRNSTotal Voting Rights
28th Jun 202312:00 pmRNSTransaction in Own Shares
1st Jun 20237:00 amRNSTotal Voting Rights
25th May 20237:00 amRNSResult of AGM
23rd May 20237:00 amRNSInterim Management Statement
2nd May 202310:00 amRNSTotal Voting Rights
19th Apr 202310:00 amRNSTransaction in Own Shares
13th Apr 20231:00 pmRNSDividend Declaration
4th Apr 20236:07 pmRNSAnnual Financial Report
3rd Apr 20237:00 amRNSTotal Voting Rights
27th Mar 20231:00 pmRNSRealisation of investment: Tharstern Group Limited
1st Mar 20237:00 amRNSTotal Voting Rights
6th Feb 20236:20 pmRNSIssue of Equity and Total Voting Rights
1st Feb 20237:00 amRNSTotal Voting Rights
31st Jan 202311:06 amRNSIssue of Supplementary Prospectus
27th Jan 20232:00 pmRNSNet Asset Value(s)
17th Jan 20235:16 pmRNSDirector Declaration
16th Jan 20237:00 amRNSCHANGE OF ALLOTMENT DATE
22nd Dec 20229:34 amRNSTransaction in Own Shares
5th Dec 20225:49 pmRNSTHE OFFER FOR SUBSCRIPTION IS NOW FULLY SUBSCRIBED
5th Dec 20224:00 pmRNSPartial realisation of investment - EOTH Limited
28th Nov 20228:34 amRNSTransaction in Own Shares and total voting rights
17th Nov 20227:00 amRNSDirector/PDMR Shareholding
16th Nov 20225:41 pmRNSIssue of Equity and Total Voting Rights
9th Nov 20223:40 pmRNSNet Asset Value(s)
9th Nov 20223:00 pmRNSInterim Management Statement
17th Oct 20221:52 pmRNSOffer for Subscription – Update
17th Oct 20229:00 amRNSOffers for Subscription Now Open for Applications

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.